Two Options the sweetest among them is bitter: Fournier-gangrene associated with sodium-glucose co-transporter 2-inhibitors

The authors discuss a case of sodium-glucose co-transporter 2 inhibitor associated with Fournier-gangrene in a patient with type-2 diabetes millets. The patient had extensive surgical intervention and skin graft but succumbed to her disease.

[1]  C. Kortepeter,et al.  Fournier Gangrene Associated With SodiumGlucose Cotransporter-2 Inhibitors , 2019, Annals of Internal Medicine.

[2]  I. Shergill,et al.  Fournier’s gangrene and its emergency management , 2006, Postgraduate Medical Journal.

[3]  Kira B. Harris,et al.  The Clinical Efficacy and Safety of Sodium Glucose Cotransporter‐2 Inhibitors in Adults with Type 2 Diabetes Mellitus , 2013, Pharmacotherapy.

[4]  Mathew D. Sorensen,et al.  Fournier's Gangrene: population based epidemiology and outcomes. , 2009, The Journal of urology.

[5]  K. Johnsson,et al.  Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin. , 2013, Journal of diabetes and its complications.

[6]  B. Voelzke,et al.  Presentation and Diagnosis of Fournier Gangrene. , 2017, Urology.

[7]  K. Hureibi,et al.  The development of Fournier's gangrene following rubber band ligation of haemorrhoids , 2013, BMJ Case Reports.

[8]  P. Dasgupta,et al.  Fournier's gangrene. A clinical review. , 2016, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[9]  N. Eke,et al.  Fournier's gangrene: a review of 1726 cases , 2000, The British journal of surgery.

[10]  I. Thompson,et al.  Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangrene. , 2002, Urology.

[11]  N. Tatonetti,et al.  Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS) , 2014, Drug Safety.

[12]  P. Norman,et al.  Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study , 2015, Cardiovascular Diabetology.

[13]  P. Riegels-Nielsen,et al.  [Fournier's gangrene]. , 1984, Ugeskrift for laeger.

[14]  L. Geiss,et al.  Declining Rates of Hospitalization for Nontraumatic Lower-Extremity Amputation in the Diabetic Population Aged 40 Years or Older: U.S., 1988–2008 , 2012, Diabetes Care.

[15]  Olga Hilas,et al.  Canagliflozin (invokana), a novel oral agent for type-2 diabetes. , 2013, P & T : a peer-reviewed journal for formulary management.